Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 5Spondylarthropathies 1Spondylarthritis 1Inflammatory Bowel Diseases 1Infections 1Cardiovascular Diseases 1

Interventions

Infliximab 5Tea 3Polyethylene Glycols 3Blood Specimen Collection 3Standard of Care 2MEDI2070 2Lidocaine 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Colonoscopy 2CT-P13 2Biopsy 2Adalimumab 2sodium phosphate 1purine 1prucalopride 1polyethylene glycol 400 1picosulfate sodium 1golimumab 1fumaric acid 1cabozantinib 1Tumor Necrosis Factor Inhibitors 1Thrombin Time 1Surveys and Questionnaires 1Surgical Tape 1Sulfasalazine 1Spectrum Analysis, Raman 1Specimen Handling 1Single-Balloon Enteroscopy 1Registries 1Proctocolectomy, Restorative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammatory Bowel Diseases × Tumor Necrosis Factor Inhibitors × Clear all
NCT06601595 2024-09-19

Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital

Assiut University

Not yet recruiting
100 enrolled

Inflammatory Bowel Diseases, Spondylarthropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡